Abstract:Brief Introduction Cardiovascular disease is a leading cause of death, while the progression of the disease is closely related to the damaged endothelial cells (ECs) on the vessel wall. Regenerative medicine is now focused on the generation of functional cells to be used to replace those cells, in which induced pluripotent stem cells (iPSCs) have the great potential. iPSCs are an attractive option to derive new, fully functional ECs to regenerate damaged vasculature. Methods In this study we have generated iPSCs from human fibroblasts using viral induction of the four reprogramming transcription factors (OCT4, SOX2, KLF4, and c-MYC) or using a DNA-free integration method based on a single plasmid transfection and neomycin selection. iPSCs generated by plasmid transduction and selection was faster and provided a higher efficiency of colony formation. Colonies obtained using both methods were isolated, expanded and fully evaluated according to the standard criteria of iPSCs characterisation, including morphology, pluripotent marker expression, alkaline phosphatase staining, and teratoma formation. Results Human iPSCs were differentiated towards vascular cell lineages and specific to ECs. To this end, human iPSCs were seeded on collagen IV and cultured in the presence of Vascular Endothelial Growth Factor (VEGF). Time course experiments revealed the ability of iPSCs to differentiate into ECs and also revealed a greater potential to derive ECs from pluripotent cells generated by transient transfection. In an attempt to obtain a pure population of ECs, iPSCs cells were pre-differentiated into an early progenitor stage and CD34 selection was performed. The CD34+ cells were differentiated into ECs demonstrating a higher efficiency and led to greater homogeneity in derived ECs, expressing in high levels endothelial markers such as VE-Cadherin, PECAM1, KDR, eNOS, vWF. During iPSCs differentiation into ECs, the gene SETSIP (similar to SET protein) was found to be up-regulated. In order to define the mechanistic role of SETSIP, the protein was over-expressed and this markedly enhanced EC differentiation. Conversely, when SETSIP was knockdown by shRNA, EC differentiation was significantly suppressed. Importantly, immunofluorescence staining showed a nuclear translocation for SETSIP during EC differentiation and subsequent luciferase assays indicated that SETSIP and not SET protein induced VE-Cadherin transcriptional activation in the ECs. Conclusion In this study we have shown that CD34 positive cells derived from pre-differentiated human iPSCs have the potential to differentiate into ECs. SETSIP appears to have a critical role in this process though control of VE-Cadherin transcriptional activation. Ongoing studies that identify the key mechanisms controlling iPSC-derived EC-differentiation have considerable relevance for regeneration of damaged vasculature in a range of diseases.

Conversion of Stem Cells from Apical Papilla into Endothelial Cells by Small Molecules and Growth Factors.

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

222 Generation of Functional Endothelial-Like Cells Enabling Therapeutic Angiogenesis from Human Smooth Muscle Cells

Directed Differentiation of Human Embryonic Stem Cells to Neural Crest Stem Cells, Functional Peripheral Neurons, and Corneal Keratocytes

Conversion of Human Fibroblasts to Functional Endothelial Cells by Defined Factors.

Conversion of human adipose-derived stem cells into functional and expandable endothelial-like cells for cell-based therapies

Sca-1(+) Progenitors Derived from Embryonic Stem Cells Differentiate into Endothelial Cells Capable of Vascular Repair after Arterial Injury

Transdifferentiated Human Vascular Smooth Muscle Cells Are A New Potential Cell Source for Endothelial Regeneration

Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation

Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2

Non-genetic Direct Reprogramming and Biomimetic Platforms in a Preliminary Study for Adipose-Derived Stem Cells into Corneal Endothelia-Like Cells.

Hepatocyte Growth Factor Promotes Differentiation Potential and Stress Response of Human Stem Cells from Apical Papilla

In Vitro Differentiation of Human Adipose-Derived Mesenchymal Stem Cells into Endothelial-Like Cells

Exosomes Derived From Stem Cells From Apical Papilla Promote Craniofacial Soft Tissue Regeneration Through Enhancing Cdc42-Mediated Vascularization

Hypoxia modulates the differentiation potential of stem cells of the apical papilla

Derivation and Characterization of Endothelial Cells from Porcine Induced Pluripotent Stem Cells

Direct Reprogramming of Fibroblasts into Endothelial Cells Capable of Angiogenesis and Reendothelialization in Tissue-Engineered Vessels

Microfluidic Single-Cell Analysis Shows That Porcine Induced Pluripotent Stem Cell-Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation

212 HUMAN INDUCED PLURIPOTENT STEM CELLS DIFFERENTIATE INTO PURE POPULATIONS OF ENDOTHELIAL CELLS MEDIATED BY SET SIMILAR PROTEIN THROUGH VE-CADHERIN TRANSCRIPTIONAL ACTIVATION

Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways.

Exosomes derived from stem cells from apical papilla promote craniofacial soft tissue regeneration by enhancing Cdc42-mediated vascularization